Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

A single fecal microbial transplant can modulate the microbiome and improve the clinical manifestations of colitis in an animal model

The transplantation of the fecal microbiota restores the intestinal microbiota and, in combination with anti-inflammatory drugs, can be a good candidate for treatment for inflammatory bowel diseases.

News

VHIR receives almost € 700.000€ from La Marató 2018 for two research projects in pediatric oncology

The projects of Dr. Soledad Gallego and Dr. Josep Roma has been awarded for his excellence in research and the funding granted will allow them to improve the treatments and the quality of life of the children.

News

Rivaroxaban would almost double the risk of recurrent thrombosis in patients with antifosfolipid antibody syndrome compared with warfarin

Rivaroxaban does not show inferiority compared to vitamin K (warfarin) antagonists for the treatment of antifosfolipid antibody syndrome.

News

VHIR signs a donation agreement with the Assisted Human Reproduction Center of Barcelona

This research scholarship aims to study and deepen the knowledge of the antibodies that are believed to cause trophoblast injury and / or placental vessels

News

The Asociación Pulseras Candela will finance €150,000 a VHIR research project in a type of pediatric tumor of the central nervous system

Pediatric ependymoma is a highly aggressive tumor of the central nervous system that remains incurable in approximately 40% of cases.

News

More than 150 people discover the interior of Vall d'Hebron during the 48H Open House BCN

At the VHIR, visitors could know the crop room, the Neuromuscular and Mitochondrial Pathology Laboratory, the freezer room and the High Technology Unit,

News

New paths for therapeutic strategies aimed at reducing reperfusion injury after a heart attack

The degradation of some proteins at early stages after myocardial infarction weakens cardioprotective pathways during restoration of blood flow.

News

The winners of the Vall d'Hebron Photographic Contest 2018 collect their work in sheet format

A total of 53 photographs were presented in the 2018 edition, of which 26 corresponded to the Scientific Photography category.

News

Vall d'Hebron participates in the BCN Science 2019 Festival

The Festival will take place on the weekend of October 26 and 27 at the Moll de la Fusta in Barcelona and Vall d'Hebron will organize 6 activities to bring science closer to the public.

News

The solidarity race Nick Horta allocates more than € 5,000 to the ‘Dream of Colors’ campaign to fight women's cancer

The campaign 'Dream of colors' contributes to the investigation against the cancer of the woman and the improvement of the well-being of the health of all the women who suffer it.

News

The basic and clinical research in Vall d'Hebron awarded by the Congress of the Spanish Society of Nephrology

Vall d'Hebron professionals have received a grant in each of the two categories, basic research, clinical research and a grant to conduct clinical practice guides.

News

Vall d'Hebron identifies a new cell type as the main target and reservoir in the tissues of people infected with HIV

Memory-resident cells (TRM) are one of the largest reservoirs of HIV, since they are the most abundant cells in peripheral tissues.

News

A new research from VHIR links the mtDNA levels with the risk of parkinsonism in patients with spastic paraplegia

The study focused on characterizing the symptoms of 35 patients in which the genetic alterations present in SPG7, the levels of mtDNA and the clinical characteristics were studied.

News

System and criteria for prioritizing applications for grants for the recruitment of new research staff (FI) by 2020

The AGAUR has published DOGC No. 7970, dated September 30, 2019, the call for grants for the recruitment of new research personnel by the year 2020 (FI-DGR 2020).

News

El VHIR obre les seves portes amb motiu del 48H Open House BCN

La visita, que podrà realitzar-se dins el 48H Open House BCN, permetrà conèixer el bloc quirúrgic de l'Hospital General, l'edifici Mediterrània del VHIR i el VHIO.

News

El VHIR participa en el projecte Immune-Image per desenvolupar noves eines diagnòstiques per detectar la dinàmica de certes cèl·lules immunològiques in vivo amb PET/TC

En el marc projecte Immune-Image, el VHIR investigarà nous radiofàrmacs per l'estudi de les cèl.lules immunitàries en colitis ulcerosa i en oncologia.

News

Amics Joan Petit Nens amb Càncer Fundació lliura 60.000€ per a la recerca del càncer infantil

Gràcies a les aportacions de la Fundació Joan Petit s'han pogut establir línies de recerca en tumors cerebrals.

News

Vall d’Hebron and ”la Caixa” present a pioneering space to study the brain of patients with migraine: the Migraine Adaptive Brain Center

A pioneering space to study the brain of patients with migration that will attend more than 8,000 people a year and that also aims to empower patients to become their own prescribers.

News

Modis Therapeutics, startup amb tecnologia llicenciada pel VHIR, és adquirida per Zogenix per 250M de dòlars

El principal producte de Modis és MT1621, una teràpia combinada de desoxinucleòsids per tractar la deficiència de timidina quinasa 2, que va ser desenvolupada pel Dr. Ramon Martí i el Dr. Michio Hirano.

News

Vall d’Hebron, segon classificat al CAGI Challenge Internacional de predicció del significat clínic de variants en gens de càncer de mama i ovari hereditaris

Es tracta d'un concurs en què la comunitat bioinformàtica de tot el món presenta les seves prediccions per diferents conjunts de variants patogèniques associades a diferents malalties genètiques.